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ABSTRACT
Development of a Rapid Riboflavin Growth-Based Assay Using Lactobacillus
rhamnosus. 
(December 2005)
Jennifer L. Golbach, B.S.,
University of Wisconsin-River Falls
Chair of Advisory Committee: Dr. Steven C. Ricke
Riboflavin is an essential part of the human diet.  Although the United States
does not have a major problem with a riboflavin deficiency, other regions of the world
do.  This is especially true for those regions whose main subsistence is rice.  To help
prevent and control riboflavin deficiencies, many cereal grains are now being fortified
with riboflavin.  The recommended dietary allowance of riboflavin is 1.1-1.6 mg per day. 
This value increases slightly for pregnant women, breast feeding women, and athletes. 
Because riboflavin is an essential part of the diet, it is important to ensure that the
minimum requirements for this nutrient are met.  By determining the amount of
riboflavin in food products, an accurate estimate of daily riboflavin intake can be
determined.  The AOAC (Association of Official Analytical Chemists) approved
microbiological riboflavin assay can be tedious and time consuming.  A faster approach
to the riboflavin assay would greatly benefit the food industry.  By scaling down the
assay to microtiter plates both, time and materials can be conserved.  Use of microtiter
plates would also allow for numerous samples to be assayed simultaneously.  The goal
for developing the microtiter plate assay is to obtain results more rapidly while
maintaining the accuracy and precision of the AOAC ( method 940.33I) tube assay.    
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1CHAPTER I
INTRODUCTION
Riboflavin, also known as vitamin B2, is an important dietary requirement for the
humans and animals.  It is essential for normal growth and development as well as the
production and regulation of certain hormones and the formation of red blood cells.  It is
also important for the cellular metabolism and the production of biological energy
through the electron-transport system (Choe et al., 2005).  Although plants are capable of
synthesizing riboflavin, animals are not capable of synthesizing or storing large amounts
riboflavin, so there is a constant need for it to be included in the diet (Cataldi et al.,
2002).
The most practical approach for quantifying the amount of riboflavin in samples
is the microbiological assay utilizing Lactobacillus rhamnosus.  This procedure has the
advantage of reducing space, time, equipment, and trained personnel over other
analytical techniques such as HPLC (high performance liquid chromatography),
fluorescence, and animal studies (Voigt and Eitenmiller, 1985).  Also, L. rhamnosus is
non-pathogenic thus there are little concerns for working with it in the laboratory (Sneath
et al., 1986).  By making adaptations of the microbiological tube assay to microtiter 
plates, more samples can be assayed at one time.  The microtiter plate adaptation will
also save on materials and labor.  
Studies to determine the amount of riboflavin in food sources as well as animal
feeds  are important to ensure that the appropriate quantity is available for consumption.
___________
This thesis follows the style of the Journal of Food Science.
2Although deficiencies in the Unites States are rare, inadequate intake in other
geographical areas is a problem where the main staple is rice.  Fortification of cereals
can greatly reduce riboflavin deficiency in these areas (McNulty et al., 1996).
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LITERATURE REVIEW
History of Riboflavin
In the early part of the twentieth century, “factor B” was found in the watery part
of milk that was essential for animals fed a purified diet that consisted of purified fat,
carbohydrate, protein, and mineral salts.  “Factor B” was found to be an amine from
which the name “vitamine” was coined and which stood for “vital amines” (Bender,
2002).  Further studies showed that not all vitamins were chemically made up of amines
so the “e” on the end of the word was dropped (Bender, 2002).  The factor B was
discovered to be a mixture of a number of compounds that performed different functions
in the body.  One of these compounds was riboflavin or vitamin B2 (Bender, 2002).
When riboflavin was first discovered, it was named according to the food
component it was extracted from.  When discovered in milk, it was referred to as
lactoflavin, and when discovered in eggs, it was referred to as ovoflavin.  Later, it was
called vitamin G because of the green fluorescent pigment isolated from whey, and
finally, it was called vitamin B2 or riboflavin (Northrop-Clewes and Thurnham, 2002 ;
Carpenter, 2003).  The accepted chemical name for riboflavin is 7,8-dimethyl-10-1'-D-
ribityl-isoalloxazine.  The flavin ring is methylated at positions 7 and 8 and contains a D-
ribityl moiety at position 10 (Eitenmiller and Landon, 2000).  Riboflavin was discovered
as a “yellow growth factor” in the heat-stable portion of antipellegra extracts.  In 1935, it
was synthesized in the lab, and by 1938, its structure was determined (Villamor et al.,
2003).  Commercial riboflavin is either generated by chemical synthesis or microbial
4fermentation, the latter of which is the most common and is used to produce most of the
riboflavin (Choe et al., 2005).
History has shown that diet has been a common way to prevent and treat ailments
such as rickets, night blindness, pellagra, and scurvy, but it was not until the end of the
nineteenth century that specific compounds in foods were determined to be vital for
normal bodily functions.  Vitamins have traditionally been identified as being either fat
soluble such as vitamin A or water soluble such as riboflavin (Villamor et al., 2003).
Compounds are confirmed to be vitamins by proving that a deficiency will cause
a specific deficiency disease and/or abnormal metabolic signs.  Also, proof is needed that
demonstrate that when the vitamin is restored to the diet that the symptoms of the disease
and/or metabolic abnormalities disappear (Bender, 2002).  It is not enough proof that a
compound is a vitamin if it performs a specific metabolic function in the body or that it
cures a disease because this could simply mean that the compound has a pharmacological
action and does not mean that it is necessarily essential in the diet (Bender, 2002).
Effects of Food Processing
Processing and storage of food can significantly affect the quantities of vitamins
found in dietary sources.  The factors that can affect vitamins vary depending on the
vitamin.  The principal factors that affect vitamins in food are heat, moisture, oxygen,
pH, and light (Ottaway, 2002).  One or more of these factors can be encountered using
various processing methods such as milling, fermentation, germination, extrusion, and
thermal processing (Reddy and Love, 1999).  These factors affect vitamins in the same
manner regardless of whether the vitamins occur naturally or if they are added. 
5However, the form in which a synthetic vitamin is added may enhance the stability of the
vitamin (Ottaway, 2002).
Riboflavin is regarded as one of the more stable vitamins because both riboflavin
and riboflavin-phosphate are both stable to heat and atmospheric oxygen, especially in
acidic media.  However, riboflavin is especially sensitive to sunlight and to a slightly
lesser extent to fluorescent light particularly in a liquid medium.  It is also increasingly
unstable as the pH rises (Ottaway, 2002).
Many of the foods that are consumed by humans are partially or fully processed
before they are displayed at retail and may undergo additional processing in the home
prior to consumption.  Although processing of food can make it healthier, safer, tastier,
and more shelf-stable, it can also reduce vitamins and other nutrients (Reddy and Love,
1999).  Riboflavin is a relatively stable vitamin during dehydration, -radiation, and
under various storage conditions, but it is affected by oxygen, metal sulfates, amino acid
chelates, and water activity.  Riboflavin is normally protected from -radiation by
prosthetic groups when riboflavin is bound to proteins.  The destruction of riboflavin
increases dramatically when oxygen is present during storage as well as when metal
sulfates are present.  Water activity also has an effect on riboflavin.  Almost 100% of
riboflavin is retained with moisture storage, but the loss of riboflavin increases as water
activity increases (Choe et al., 2005).
A study done by Prodanov et al. (2004) determined riboflavin loss in legumes
when soaked and cooked.  The results showed that soaking in sodium bicarbonate
significantly decreased the riboflavin content of faba beans and chickpeas.  This also was
the case for those soaked in sodium bicarbonate and, then, cooked.  Lentils, on the other
hand, had a marked increase of riboflavin content when soaked in citric acid, water, or
6sodium bicarbonate.  The only decrease of the riboflavin content was when the lentils
were soaked in sodium bicarbonate and, then, cooked.  The increase in lentil riboflavin
content can be explained by the microbial activity found in the lentil cover.  Immediately
after humidification of lentil seeds, bacteria, mainly certain Lactobacillus species, are
able to synthesize riboflavin (Prodanov et al., 2004).
Thermal processing of soymilk was studied to determine whether there was an
effect on riboflavin content.  Many Asian countries drink more soymilk than dairy milk,
and each can provide a significant amount of dietary riboflavin.  The amounts of
riboflavin in soymilk are comparable to those in dairy milk.  A study done by Kwok et
al. (1997) revealed that thermal processing has an insignificant effect on the riboflavin
content of soymilk.
Food Fortification
Fortification of foods with riboflavin is sometimes necessary when the foods
commonly eaten in different parts of the world do not provide enough of the vitamin to
prevent a deficiency.  The most common foods fortified with riboflavin are breakfast
cereals.  Studies show that riboflavin intake increases with increased consumption of
breakfast cereals for all age groups.  This indicates that the fortification of breakfast
cereals is beneficial, especially to populations that do not consume a balanced diet rich in
certain vitamins such as riboflavin (McNulty et al., 1996).  There is strong evidence that
significant population subgroups have suboptimal intakes of certain vitamins and
minerals such as are iron, calcium, zinc, vitamins B1, B2, B6, D, and folate.  Studies
have shown that mandatory and voluntary addition of nutrients to foods can help ease the
nutrient deficiency problem in at-risk populations (Flynn et al., 2003).  Up to 200
7mg/serving of riboflavin,  the determined maximum safe addition level for this particular
vitamin, can be safely added to foods (Flynn et al., 2003).  Riboflavin is considered a
category C vitamin because there have been no adverse affects observed with excess
intake.  The safe upper intake range is almost impossible to determine due to the absence
of toxicity even at 100 times the RDA (recommended dietary allowance).  Other
vitamins that share this category are vitamin K, thiamine, pantothenic acid, and biotin
(Meltzer et al., 2003).
Because there is a loss of vitamin content during processing and consumption of
ready-to-eat foods has increased, there is an increasing need to fortify more foods with
essential vitamins (Agte et al., 2002).  Although fortification is not a replacement for a
balanced diet, it does help alleviate some of the nutritional deficiencies that some parts
of the world’s population have. 
A recent study has shown that B-group vitamin supplementation, which includes
riboflavin, to stroke victims has antioxidant and anti-inflammatory effects as well as a
homocysteine-lowering effect.  These are all positive effects jointly associated with
riboflavin that benefit stroke victims.  By supplementing riboflavin along with the other
B-group vitamins during a critical 12 hour period after a stroke enhances antioxidants
which mitigates oxidative damage to stroke patients (Ullegaddi et al., 2004).
Forms of Riboflavin
Riboflavin is a building block for certain essential flavin coenzymes such as
flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD)(figure 2.1).  These
flavin coenzymes act as prosthetic groups for flavoprotein enzymes (Hoppel and Tandler,
1990).  Although riboflavin may be ingested as riboflavin, once it enters the body, it can
8be converted to other biological forms such as FMN or FAD.  This occurs when
riboflavin is phosphorylated (Fogelholm, 2000).  The phosphorylation of riboflavin to
FMN in mammalian tissues is catalyzed by a Zn2+ preferring flavokinase (McCormick,
2003a).  The structures of riboflavin, FMN, and FAD are composed of an isoalloxazine
ring with a ribityl side chain at position 10.  The modifications in the ribityl side chain
are what distinguishes riboflavin from FMN and FAD (Cataldi et al., 2002 and
Fogelholm, 2000).  The ribityl side chain is required for full vitamin activity, and it is the
alcohol form of the 5-carbon sugar, ribose (Trusswell and Milne, 1998).  
FMN and FAD function in numerous glycolysis and respiratory chain oxidation-
reduction reactions.  They are required for reaction catalyzations, dehydrogenation, and
oxidative decarboxylations as well as being involved in the respiratory chain, lipid
metabolism, the cytochrome P-450 system, and drug metabolism (Rivlin, 2002).  FMN is
needed for the synthesis of fatty acids from acetate whereas Figure 2.1: Different forms of
riboflavin present in food sources and tissues.  FAD is required for fatty acid oxidation
(Fogelholm, 2000).  Rats fed riboflavin-deficient diets showed abnormal lipid
metabolism as well as a reduction in the beta-oxidation of fatty acids (Witte and Clark,
2004).  FAD is also required for the pyruvate dehydrogenase complex, -ketoglutarate
dehydrogenase complex, and succinate dehydrogenase which are enzymes involved in
the citric acid cycle (Fogelholm, 2000).  FAD is the most common biological form of
riboflavin in tissues and circulation (Powers, 1999).
Nutrition
Riboflavin is found in a wide range of dietary sources.  The best sources are milk
and dairy products, eggs, liver, kidney, yeast extracts, and fortified cereals (Truswell and 
9Figure 2.1: Different forms of riboflavin.
10
Milne, 1998).  Even though a significant contribution of riboflavin is provided through
milk consumption, riboflavin is light sensitive and milk loses 70% of its riboflavin
content when exposed to at least 4 hours of ultraviolet light (Truswell and Milne, 1998). 
Milk stored in opaque or other containers that do not let light through do not lose as
much of the vitamin.  Animal sources have been found to provide a better source of
riboflavin than natural plant sources (Murphy, 2003; Murphy and Allen, 2003).
The dietary requirements for most vitamins, including riboflavin, have been
calculated and are referred to as the recommended dietary allowance (RDA) (Northrop-
Clewes and Thurnham, 2004).  Because dietary requirements vary between individuals,
this number represents an amount of riboflavin that should be sufficient to meet the
metabolic needs of at least 95% of the population (Northrop-Clewes and Thurnham,
2004).  Riboflavin requirement estimates are based on depletion/repletion studies.  These
studies are used to determine the minimum amount of riboflavin intake at which there is
no significant excretion of the vitamin in the urine.  The minimum adult requirement of
riboflavin is 0.5–0.8 mg/day where there is very little excretion in the urine.  When the
intake of riboflavin reaches 1.1-1.6 mg/day, the urinary excretion rises sharply indicating
that the tissue reserves are saturated (Bender, 2002).  An additional 0.3 mg/day is
recommended during pregnancy while an additional 0.5 mg/day is recommended during
lactation (Manore, 2000).  The main advantage to the urinary excretion assay is the
existence of a “breakpoint” which can be used to determine the tissue saturation point
and define the body’s requirements with a fair amount of accuracy.  This approach has
never been very popular in practice because it has been difficult to get sufficient subject
cooperation with the timed collection of urine samples as well as being a poor
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representation of riboflavin status between the ranges of mild to severe desaturation
(Bates, 1993).
Another way to determine riboflavin status in the body is the red blood cell
riboflavin pool which gives an estimate of intracellular riboflavin levels.  Most of the
riboflavin is located in the cells, especially the erythrocytes, which have four to five
times more total flavin than the serum (McCormick, 1989).  Also, the flavin levels in
erythrocytes are not influenced as much by the recent intake of riboflavin, so tests
utilizing erythrocytes give a more accurate riboflavin reading (McCormick, 1989).  This
assay has not achieved the popularity of the glutathione reductase index mainly because
tissue saturation is more difficult to define and the saturation values have a tendency to
vary between individuals (Bates, 1993).  
Riboflavin status in the body can also be determined by using the activity and
activation coefficient of glutathione reductase which is the red cell FAD-dependent
enzyme.  Erythrocyte glutathione reductase (EGR) requires not only NADPH, but also,
FAD.  This enzyme regenerates reduced glutathione from its oxidized form.  EGR
performs a critical role in finding potentially harmful intracellular reducing equivalents. 
Under normal circumstances, EGR is not saturated with FAD coenzyme which has led to
the development of biochemical assays to determine the extent of erythrocyte riboflavin
depletion (Ross and Hansen, 1992).  The “enzyme functional index” of riboflavin which
is often referred to as EGRAC (Erythrocyte Glutathione Reductase Activation
Coefficient) assay is determined by the ratio of enzyme activities with and without the
added cofactor of FAD.  This approach is closely linked to the red cell riboflavin pool
assay (Bates, 1993).  This is the most widely used assay to determine riboflavin tissue
saturation because the biological materials are relatively stable when stored frozen, only
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small amounts of blood are needed, it is discriminatory within the normal range of
values, and it provides an accurate reflection of tissue saturation over a wide range of
status values.  The one disadvantage of this test is that it fails to quantitate riboflavin
concentrations when glucose 6-phosphate dehydrogenase deficiency is also present
(Bates, 1993).
Chemistry
Oxidation/reduction reactions
Riboflavin is a major part of FMN and FAD, which catalyze a wide range of
oxidation-reduction reactions.  Riboflavin is able to accept or donate a pair of hydrogen
atoms which makes it an easy candidate for oxidation or reduction.  Flavins are capable
of one or two electron transfers which play a major role in the coupling of the two-
electron oxidation of most organic substrates to the one-electron transfers of the
respiratory chain.  The one-electron transfers to various metal substrates are conducted
through their free radical state (Massey, 2000).  Flavins are able to form portions of
redox-center enzymes through their free radical states.  Some examples are succinate and
NADH dehydrogenases, xanthine oxidase/dehydrogenase, cytochrome P450 systems,
and nitric oxide synthase (Massey, 2000).  This ability to donate and accept electrons
also makes riboflavin a highly susceptible target for photochemistry alterations by
exposure to light.  When irradiated under visible or UV light, riboflavin can produce
superoxide radicals, singlet oxygen, hydroxy radicals, and hydrogen peroxide when
atmospheric oxygen is present (Choe et al., 2005).  Flavins are versatile compounds that
are able to function as electrophiles and nucleophiles and sometimes are involved in
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catalysis.  Riboflavin and its coenzymes have a major role in the detoxification of soil
through the hydroxylation of numerous aromatic compounds (Massey, 2000).  The
oxidation of riboflavin by light, which is a radical reaction, produces lumiflavin and
lumichrome.  Lumiflavin is predominantly produced in alkali solutions, and lumichrome
is predominantly produced in neutral solutions (Fox and Thayer, 1997).
Flavoprotein reducing substrates are mainly dehydrogenated in a two-electron
reduction step, and the resulting flavin is re-oxidized by its oxidizing substrate which can
be either a two-electron step or a one-electron step.  In the one-electron step, the flavin
semiquinone is an intermediate (Massey, 2000).
Flavoproteins are able to catalyze a large diversity of reactions.  Flavoproteins
catalyze the oxidation of -hydroxyacids and -amino acids through the dehydrogenation
at the -carbon of the substrate.  This results in 2-oxo (-keto) acid or -imino acid as
primary products (Massey, 2000).  The family of proteins known as flavoprotein
disulphide reductases contain an active-site disulphide in addition to the FAD prosthetic
group.  These reactions also involve a pyridine nucleotide as one substrate and a
disulphate or dithiol as the other substrate.  The enzymes function as part of an oxo acid
oxidase multienzyme complex which reoxidizes protein-bound dihydrolipoic acid by
reducing NAD to NADH.  An example of this reaction would be glutathione reductase
utilizing NADPH to reduce oxidized glutathione (Massey, 2000).  Flavoprotein mono-
oxygenases are another example of enzymes that utilize NADH and NADPH.  These
enzymes are able to reduce FAD to form a flavin C4a peroxide when the reduced
enzyme is reacted with oxygen (Massey, 2000).
Acyl-CoA dehydrogenases are common enzymes that are involved in the
oxidation of fatty acids.  They oxidize acyl-CoA thioesters to corresponding enoyl-CoA
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esters.  The reduced flavoprotein that is formed is reoxidized through one-electron
transfers to another flavoprotein which is termed the electron-transfer flavoprotein.  In
mammals, the electron-transfer flavoprotein is oxidized by a third flavoprotein known as
electron-transfer flavoprotein-ubiquinone reductase (Massey, 2000).
Riboflavin plays a very important role in antioxidant activity in the body. 
Although riboflavin itself does not have significant antioxidant activity, it is transformed
into FMN and FAD which provide a major protective role over the oxidation of lipid
peroxides through the glutathione redox cycle (Rivlin and Pinto, 2001).  
Increased riboflavin levels in tissues has been reported to provide protection
against oxidative injury caused by oxidized forms of hemeproteins.  Studies done by Xu
and Hultquist (1991) have shown that dihydroflavin generated by flavin reductase will
react rapidly with Fe(IV)O and Fe(V)O oxidation states.  The rate of reduction is
dramatically increased by riboflavin because it is able to quickly penetrate cells.  The
riboflavin must be provided exogenously.  Another study that was done by Mack et al.
(1992) revealed that cardiac damage can be minimized by the administration of
riboflavin.  The rabbits in this study underwent 60 minutes of hypoxic perfusion while
some of them where treated with riboflavin after 55 minutes.  Following the hypoxic
perfusion, the rabbit hearts were oxygenated for 30 minutes.  The results showed that
riboflavin reduced cardiac damage when measured as the escape of LDH (Christensen,
1993).
Riboflavin has an effect on the oxidation of amino acids, especially tyrosine,
tryptophan, and histidine.  Carbon dioxide and an aldehyde are produced by riboflavin-
photosensitized oxidation of aliphatic amino acids.  Hydroxy radicals and singlet oxygen
are responsible for the photooxidation of tryptophan which has electron-rich double
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bonds and are excellent reactants for singlet oxygen oxidation.  Ascorbic acid can reduce
the tryptophan photooxidation because it interacts with excited triplet riboflavin. 
Therefore, no riboflavin is available to act on tryptophan (Choe et al., 2005).
Enzymes are also affected by riboflavin photooxidation.  The loss of enzymatic
activities is common when reactive oxygen species formed by photosensitized riboflavin
cause cross-links and protein denaturation in enzymes.  Quenchers of singlet oxygen,
such as -tocopherol acetate, -carotene, sodium azide, and ascorbic acid, can sometimes
prevent protein cross-linking and photo-degradation of enzymes (Choe et al., 2005).
Unlike lipids and proteins, carbohydrates are relatively stable when subjected to
photooxidation.  The photooxidation of glucose can occur when riboflavin is present, but
it is dependent on the riboflavin concentration, pH, and glucose concentration.  Glucose
photooxidation is directly proportional to the concentration of excited riboflavin present
(Choe et al., 2005).
Photosensitivity
Riboflavin is light sensitive, especially to UV light, and can generate reactive
oxygen species such as superoxide anions and singlet oxygen when exposed to light. 
This effect not only causes nutrient degradation, but also the off-flavor of foods (Huang
et al., 2004a).  This is especially a concern for soymilk that is not stored properly
because riboflavin can cause significant effects on the head space of oxygen depletion
and the formation of volatile compounds when exposed to light (Huang et al., 2004b).  
The photolysis of riboflavin in an aqueous solution occurs through 7,8-dimethyl-
10-(formylmethyl) isoalloxazine which is commonly known as formylmethylflavin.  This
is the intermediate which is hydrolyzed to lumichrome and lumiflavin (Ahmad et al.,
16
2004).  The photooxidation of riboflavin is classified into two mechanisms.  The first is
referred to as type I which involves electron transfer that leads to the generation of the
superoxide ion.  The second is referred to as type II which involves energy transfer that
leads to the formation of singlet O2 (Silva et al., 1999). 
Because the reaction of riboflavin with light can be such a problem, Bhowmik
and Sil (2004) examined the effects of reducing agents on retardation of riboflavin
oxidation under light.  This study found that the visible absorption spectrum of riboflavin
in aqueous solution was not affected when different reducing agents were used.  There
was little change of absorbance and no shift to the absorbance maximum which indicates
there was no interaction between riboflavin and the reducing agents.  However, the
fluorescence spectrum was affected by the reducing agents.  The fluorescence of
riboflavin was quenched in the presence of the reducing agents which confirms that there
was an excited state molecular interaction (Bhowmik and Sil, 2004).
The off-flavor in milk has been contributed to the oxidation properties of the
riboflavin present.  When the riboflavin in milk is exposed to light, it is transformed into
an excited state which can oxidize the methionine in milk to methional which has been
confirmed as a component of light induced off-flavor.  Photo-degradation of lipids has
also been linked to the off-flavor of milk.  The degradation of lipids is caused by singlet
oxygen oxidizing the fatty acids.  The singlet oxygen is found in milk when riboflavin is
present (King and Min, 1998; Bender, 2002).
Reactions with other vitamins
Photosensitized oxidation by riboflavin can cause destruction of several vitamins
including A, C, D, and E.  Vitamin A is destroyed through ring opening, and its loss
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increases with the length and intensity of light exposure.  This loss decreases with the
increase of fat content of milk.  The oxidation products produced by vitamin A
photooxidation are ethyl-(2,6,6-trimethylcyclohex-1-ene) carboxylate, retinal, 5,8-
peroxide of -ionene, 5,6-peroxide of vitamin A, and retinoic acid.  The palmitate ester
of vitamin A is also affected by riboflavin oxidation which causes cleavage of its side
chain double bonds and creates aldehyde compounds (Choe et al., 2005).  Although
ascorbic acid is an excellent antioxidant that does not absorb visible light, it is rapidly
photooxidized when riboflavin and a high concentration of oxygen are present.  The
photooxidation of ascorbic acid depends on light intensity, riboflavin, ascorbic acid, and
oxygen concentrations, pH, temperature, and the presence of other compounds (Choe et
al., 2005).  The oxidation of vitamin D is accelerated under light when riboflavin is
present via the singlet oxidation pathway, but it only occurs under light and is negligible
in the dark (Choe et al., 2005).
There have been studies that confirm riboflavin interactions with other B group
vitamins.  Due to effects of acute riboflavin deficiency on fetal development being
similar to the effects of folate deficiency, there is a possibility that the effects are
mediated by flavins on folate metabolism (Powers, 2003).  Methionine synthase is an
enzyme which converts homocysteine to methionine.  It is dependent on 5-
methyltetrahydrofolate as a methyl donor but also on vitamin B-12 as methylcobalamin
which the synthesis of is dependent on flavoproteins.  Even though there is an interaction
between vitamin B-12 and riboflavin, there is no substantial proof that riboflavin
deficiency will lead to a deficiency in vitamin B-12 (Powers, 2003).  There are also
similarities between riboflavin deficiency and pyridoxine (vitamin B-6) deficiencies. 
Riboflavin is required for the conversion of pyridoxine to its coenzyme form pyridoxal
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phosphate.  Pyridoxine phosphate oxidase, a FMN dependent enzyme, is required. 
Those organisms that are deficient in riboflavin will have a reduction in their pyridoxine
phosphate which is also required by the body (Laskshmi, 1998).  When the riboflavin
deficiency was corrected, the activity of erythrocyte pyridoxamine phosphate oxidase
increased in human subjects (Powers, 2003; Sauberlich, 1980).
Reaction with Zn
Due to the chemical structure of riboflavin, it has promise for acting as an
organic ligand to form metal ion complexes.  One of the metal ions that riboflavin can
form a complex with is zinc (Zn).  The complex formation is able to protect Zn from
precipitation into its insoluble form even in biological systems (Agte et al., 1992).  FAD
shows higher values than riboflavin for complex formation which indicates that the
adenine part of FAD may also contribute to complex formation.  Intestinal uptake of Zn
increases when in a complex with riboflavin or FAD indicating that riboflavin and FAD
can act as a carrier for Zn across the intestinal membrane (Agte et al., 1992).
Biosynthesis of riboflavin
Riboflavin is biosynthesized in plants and many bacteria, but humans and most
mammals are unable to synthesize riboflavin.  Although ruminants cannot synthesize
riboflavin, they get the majority of the vitamin from the microflora in their intestines
(Bacher et al., 2000).  Some bacteria such as the cotton pathogen, Ashbya gossypii, can
synthesize amounts of riboflavin through fermentation that is well above their metabolic
requirement (Bacher et al., 2001; Fischer et al., 2002).  This overproduction is beneficial 
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Figure 2.2: Biosynthesis of riboflavin adapted from Bender (2000).
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for companies that make commercial riboflavin for laboratory use or vitamin
supplements.
Biosynthesis of riboflavin in microorganisms is illustrated in figure 2.2.  It is
initiated with the hydrolytical opening of  the imidazole ring of GTP.  This occurs under
the release of  formate accompanied by the release of pyrophosphate.  The pyrophosphate
is catalyzed by GTP cyclohydrolase II (Bacher et al., 2000; Fischer et al., 2002).  GTP
cyclohydrolase II is also the enzyme that is inhibited by the presence of riboflavin when
there is an abundance of riboflavin and it does not need to be synthesized (Singhal and
Kulkarni, 2004).  This reaction produces 2,5-diamino-6-ribosylamino-4(3H)-
pyrimidinone 5'-phosphate which is converted to 5-amino-6-ribitylamino-2,4(1H,3H)-
pyrimidinedione 5'-phosphate using two reaction steps depending on the organism. 
These two reaction steps involve the hydrolytic cleavage of the position 2 amino group
of the heterocyclic ring and the reduction of the ribosyl side chain.  This produces the
ribityl side chain of the vitamin riboflavin.  In eubacteria, the deamination precedes the
side chain reduction, while in yeasts and fungi, the reduction precedes the deamination
(Bacher et al., 2000).
The 5'-phosphate is dephosphorylated so it can serve as a substrate for
6,7-dimethyl-8-ribityllumazine synthase which condenses the dephosphorylated 5-
amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione with 3,4-dihydroxybutanone 4-
phosphate (Bacher et al., 2000).
The final biosynthesis step is the dismutation of 6,7-dimethyl-8-ribityllumazine
catalyzed by riboflavin synthase which also produces a second product, 5-amino-6-
ribitylamino-2,4(1H,3H)-pyrimidinedione.  The entire biosynthesis of riboflavin requires
one equivalent of GTP and two equivalents of ribulose 5-phosphate.  Only four of the
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seventeen riboflavin carbons are not derived from the pentose phosphate pool (Bacher et
al., 2000).
Metabolism
Riboflavin plays many key metabolic roles throughout the body.  It is important
for the production of energy through the coenzyme activity of FAD in the respiratory
chain.  Many biological reactions that involve oxidation and reduction are mediated by
flavin coenzymes.  Antioxidant defense is an important function of the body that may be
compromised when there is a riboflavin deficiency because the regeneration of
glutathione in the glutathione peroxidase antioxidant system requires riboflavin
(Villamor et al., 2003). 
Approximately 50% of the riboflavin found in plasma is free riboflavin, 44% is
FAD, and the remainder is FMN (Bender, 2002).  Riboflavin is mostly protein-bound in
plasma where free riboflavin binds to both albumin and - and -globulins.  Riboflavin
as well as the coenzymes also bind to immunoglobulins.  FMN and FAD that are not
bound to proteins are rapidly hydrolyzed to free riboflavin and diffuse into the
bloodstream (Bender, 2002).
Absorption
Before absorption of riboflavin derivatives can occur, the vitamin must be
hydrolyzed because very little free riboflavin is found in natural sources.  This occurs by
pyrophosphatase, cleaves FAD and FMN.  Alkaline phosphatase, which liberates
riboflavin from FMN, releases riboflavin that is ready to be absorbed (McCormick,
1989).  Commercial multivitamin preparations are the main source of free riboflavin
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(Rivlin and Pinto, 2001).  Flavins are absorbed in the upper gastrointestinal tract
involving a transport method utilizing a dephosphorylation-rephosphorylation method
phosphates present in the intestinal brush border of the upper intestinal tract (Baker,
1995).  The action of hydrolases from the brush-boarder membrane, mainly  rather than
passive diffusion.  Transport also involves a saturable ATP-ase active transport system
(McCormick, 1990).  In the erythrocyte, the riboflavin is trapped metabolically by
phosphorylation catalyzed by flavokinase (McCormick, 2003b).  After the riboflavin
uses active transport to cross into the enterocyte membranes, it is transported to the liver
and peripheral tissues in the portal and systemic circulations (Halstead, 2003).  An
estimate of riboflavin absorption at any one time is 25 mg which is roughly 15 times
higher than the RDA.  The excess amounts that may be consumed will pass through in
the urine and stool (Rivlin and Pinto, 2001).  It is generally believed that animal sources
of riboflavin are better absorbed than plant sources. 
A number of physiological factors have been shown to affect the absorption of
riboflavin in the intestines.  Certain metals such as copper, zinc, iron, and manganese
have been shown to chelate riboflavin and FMN, and inhibit riboflavin absorption (Groff
and Gropper, 1999).  Diets high in psyllim gum seem to decrease the rate of riboflavin
absorbed, but diets high in bran seem to have no effect.  Although this diet appears to
affect the rate of absorption, there are no indications that it affects the overall amount of
riboflavin absorbed (Rivlin and Pinto, 2001).  Alcohol, however, affects both the rate of
absorption and the amount absorbed.  There are indications that recovering alcoholics
respond better to vitamin supplements of riboflavin rather than dietary sources (Rivlin
and Pinto, 2001).  Riboflavin absorption is increased by the presence of food as well as
bile salts. The increased absorption with the presence of food may be due to the
23
decreasing rates of gastric emptying and intestinal transit which prolongs the contact of
dietary riboflavin with the absorptive surface of the intestinal cells (Rivlin and Pinto,
2001).  Studies have been done with cultured Caco-2 human intestinal epithelial cells
which have been helpful for achieving a better understanding of riboflavin absorption. 
These studies showed that riboflavin uptake is Na+ and pH independent in these specific
cells, but energy and temperature dependent in instances where uptake occurred at 37C,
but this was not the case when uptake occured at 4C (Said and Ma, 1994).  There is
controversy over riboflavin being Na+ independent because in other studies it has been
demonstrated that riboflavin and Na+ concentrations are linked (Rivlin and Pinto, 2001). 
These studies also showed that riboflavin was susceptible to the inhibitory effects of
sulfahydryl group reagents and amiloride (Said and Ma, 1994).
Different types of cells have a significantly different mechanism for importing
riboflavin.  The absorption of riboflavin by enterocytes seems to be Na+-dependent.  The
absorption in the proximal small intestine is similar to the absorption of amino acids and
glucose.  The hepatocytes in the liver exhibit an initial rapid uptake of riboflavin
followed by a slower passive diffusion.  The riboflavin becomes metabolically trapped in
the hepatocytes because it is phosphorylated by flavokinase.  The uptake by hepatocytes
is relatively insensitive to the Na+ concentration (McCormick, 1989).  
Excretion
Excretion of riboflavin occurs mainly in the urine.  Riboflavin undergoes limited
metabolism prior to excretion, and mainly free riboflavin is found in the urine (Groff and
Gropper, 1999).  Unbound riboflavin and riboflavin phosphate that circulate in the
plasma are filtered by the glomerous, the phosphate is removed from the riboflavin, and
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it is excreted by the kidney (Groff and Gropper, 1999).  Riboflavin bound with cysteine
and histidine can also be found in the urine if it was absorbed in that form by the
gastrointestinal tract or if it is generated in body cells from the degradation of
flavoenzymes such as succinate dehydrogenase and monoamine oxidase (Groff and
Gropper, 1999).  The urinary excretion of riboflavin can be observed a couple of hours
after ingestion if the total quantity is greater than 1.7 mg which is similar to what is
found in a vitamin pill.  The color of the urine will deepen in color to a brighter
orangish-yellow when there is an excess of riboflavin (Groff and Gropper, 1999).  There
are also small amounts of free riboflavin that can be secreted into the bile which is then
found in the feces.  Fecal riboflavin may also arise from metabolic processes of the
intestinal flora (Groff and Gropper, 1999).
Cell functions
The hepatic aryl-hydrocarbon hydroxylase system in the liver is an FAD-
dependent P450 cytochromic c enzyme.  The cytochromic P450 enzymes are enzymes
that shift the absorbance peak of cytochrome chromophore from 420 to 450 nm when it
is reduced with carbon monoxide.  Many of these P450 enzymes are located in the
microsomal fraction where they assist in the metabolism of assorted drugs and toxins as
well as being involved in other pathways such as the adrenal steroid biosynthetic
pathway (Ross and Hansen, 1992).
The riboflavin carrier protein (RCP) is critical in the reproduction processes of
birds and mammals.  The vitamin carrier proteins are present in the blood and other
bodily fluids, and they ensure that there is optimal bioavailability for growth,
25
metabolism, and reproduction.  These proteins facilitate the dietary absorption, selective
transport, and protection against loss by metabolic degradation (Adiga et al., 2002).
The carrier proteins stoichiometrically and reversibly bind vitamins with high
affinity and receptor specificity.  The riboflavin remains biologically inert while bound
to the carrier protein which permits the dissociation of the unmodified vitamin.  This
allows for optimal utilization at the designated location.  The riboflavin carrier protein is
induced de novo as a reproduction strategy to promote vitamin deposition in the
developing oocytes and embryos. The carrier protein sequesters the riboflavin from the
maternal circulation and deposits it in the oocyte or embryo against a concentration
gradient.  Riboflavin has a high fetal to maternal ration of 4:1 (Adiga et al., 2002).
The mitochondria are an important part of a cell, and riboflavin plays a vital role
in the mitochondria’s function in the cell.  A study was conducted by Barile et al. (2000)
to determine the FAD cycle in the mitochondria of rat liver since huge amounts of FAD
and FMN are found in the mitochondria.  The objective was to determine the process by
which the mitochondria provide and regulate their flavin cofactor pool.  The riboflavin
and FAD found in the mitochondria are precursors for the synthesis of mitochondrial
flavin cofactors essential for the normal functioning of the mitochondria.  The riboflavin
is transported into the mitochondria via carrier proteins, and FAD is synthesized by FAD
synthetase which is localized in the matrix.  The matrix has a substrate pair of
mitochondrial ATP and FMN synthesized from riboflavin through the putative
mitochondrial riboflavin kinase.  The synthesis of FMN and FAD occurs in the cytosol
where the enzymes riboflavin kinase and FAD synthetase exist.  The mitochondria can
synthesize FAD from the FMN which is taken up through carrier proteins.  Because
mitochondria possess FAD pyrophosphatase and FMN phosphohydrolase, FAD and
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FMN can be catalyzed to produce riboflavin in the intermembrane space (Barile et al.,
2000). Riboflavin is important in the mitochondria and peroxisomes because this is
where the -oxidation of fatty acids occurs.  The mitochondrial pathway requires the
import of a long chain fatty acyl-CoA which is acted upon by an FAD-dependent acyl-
CoA dehydrogenase.  This reaction produces an  - unsaturated acyl-CoA and FADH2. 
The electrons produced from the FADH2 as well as NADH are introduced into the
electron transport chain to generate two and three ATP molecules, respectively (Ross and
Hansen, 1992).
Elevated homocysteine concentrations in the blood have been associated with an
increased risk for cardiovascular disease and decreased cognitive function. 
Homocysteine metabolism is regulated by various enzymes and B-vitamins including
riboflavin.  Methylene tetrahydrofolate is a coenzyme of riboflavin, and it catalyzes N5-
N10 methylene tetrahydrofolate to N5-methyl tetrahydrofolate which is required for
remethylation of homocysteine to methionine.  Low blood concentrations of B-vitamins
that are involved in the methionine metabolism can lead to elevated levels of
homocystein (Ganji and Kafai, 2004; Lin et al., 2004).
Riboflavin Deficiencies
Although riboflavin deficiencies are not commonly seen in the United States, it is
a significant public health problem in other areas of the world such as those populations
who’s main staple is rice (Laskshmi, 1998).  Fortunately, riboflavin deficiencies are
rarely, if ever, fatal due to the efficient conservation and reutilization of tissue riboflavin
when there is a dietary deficiency.  The only riboflavin that will be lost during a
deficiency is the small amount that is covalently bound to enzymes (Bender, 2002). 
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Riboflavin deficiency may be acute or chronic.  The acute deficiency is caused by borate
poisoning which replaces riboflavin in binding sites, forms a complex with the ribityl
side chain, and increases loss of the vitamin to the urine.  Chronic riboflavin deficiency
is unknown as an endemic disease because of the widespread consumption of milk and
cheese.  It is, however, a problem in many areas of the world where the population
subsists on unenriched cereal diets (Roe, 1991).  Riboflavin is widespread throughout
many different foods and diets, so most diets will provide a minimal amount of
riboflavin to permit maintenance of central metabolic pathways (Bender, 2002).  In the
liver, there is only a four-fold difference between deficiency and saturation, and in the
central nervous system, there is only a 35% difference between deficiency and saturation
(Bender, 2002). Riboflavin deficiency usually does not occur by itself, but is more often
associated with other water-soluble vitamin deficiencies (Eitenmiller and Landen, 2000).
Riboflavin deficiency is usually distinguished by lesions of the margin of the lips
and the corners of the mouth, desquamation of the tongue, sebhorreic dermatitis, filiform
excrescences affecting the nasolabial folds, eyelids, and ears, and abnormalities of the
skin around the vulva, anus, and prepuce (Bender, 2002).  Deficiencies can also cause
conjunctivitis with vascularization of the cornea and opacity of the lens.  This is the only
part of the disease where the biochemical cause is known.  Glutathione reductase is a
flavoprotein that is particularly sensitive to riboflavin depletion, and glutathione is
important in maintaining the normal clarity of the crystalline in the lens of the eye
(Bender, 2002).  Although riboflavin is required for the proper functioning of the eye, it
can also be damaging.  The vitamin C that is present at high concentrations in normal
lenses plays a very important role in inhibiting the photosensitization process that can
occur to riboflavin in the eye (de La Rochette et al., 2000).
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Factors other than sub-optimal intake can cause a riboflavin deficiency as well. 
Adrenal insufficiency and interactions with alcohol or other drugs such as psychotropic,
chemotherapeutic, and antimalarial medications can cause a deficiency in riboflavin. 
Some of these drugs include chloromazine, imipramine, amitriptyline, doxorubicin, and
quinacerine (Villamor et al., 2003 and Rucker, 2000).  These drugs have structures that
resemble riboflavin and act as antagonists that inhibit the conversion of riboflavin to its
coenzyme forms by inhibiting flavokinase activity.  The administration of adriamycin
which is an anti-cancer drug also inhibits FAD biosynthesis (Laskshmi, 1998).
Glutathione reductase activity is important for red blood cells to effectively
regulate cellular redox potential through glutathione peroxidase.  When there is an
insufficient amount of riboflavin in the diet, studies in animals have shown there is an
increased potential of the cell to sustain oxidative injury causing hemolytic anemia
(Harmatz et al., 2003).
The main metabolic effect of riboflavin deficiency is on lipid metabolism which
causes a lower metabolic rate (Bender, 2002).  Study animals require 15-20% more feed
to maintain the same weight as that of control animals, and feeding a diet high in fat to
riboflavin deficient animals reveals a more differentiated impairment of growth (Bender,
2002).
Although a report of personality changes in riboflavin deficiency have not been
substantiated, riboflavin plays a role in thyroxine metabolism and a deficiency may
contribute to the pathophysiology of some mental illness (Powers, 2003).  Symptoms of
neurodegeneration and peripheral neuropathy have been observed and documented in
studies of riboflavin deficiency in young, rapidly growing chickens, racing pigeons, and
rats.  There is little information about this condition with humans, but there is a
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documented case of a 2.5 year old girl who was riboflavin deficient and exhibited
neurological abnormalities such as anemia and visual impairment (Powers, 2003).
Some studies demonstrate that there were both increases of cancer and possible
protection from cancer with the deficiency of riboflavin (Powers, 2003).  Because some
carcinogens are metabolized by flavin-dependent enzymes, riboflavin deficiency in these
cases may enhance or diminish the effect of the carcinogen.  Recently, one work showed
there was a connection between deficiency of riboflavin and an increase in DNA
breakage in rats when exposed to hepatocarcinogens.  Because of the DNA breakage,
there was induction of the repair enzymes which help resistance to malignant
transformations to be enhanced in the deficient animals (Powers, 2003).  
Animals can also exhibit signs of deficiency.  Some symptoms are similar to
those seen in human patients.  The most common signs of deficiency are cessation of
growth, dermatitis, hyperkeratosis, slopecia, and vascularization of the cornea (Trusswell
and Milne, 1998).  In the fetus, abortion or skeletal malformations are possible.  Also, in
some species, anemia, fatty liver, and neurological symptoms have been observed
(Trusswell and Milne, 1998).  A problem found in equines is uveitis which is also known
as moonblindness and can occur from but is not limited to a riboflavin deficiency.  This
disease affects the horses night vision which is normally relatively good (Goff, 2004).
Riboflavin deficiencies have an effect on the body’s normal handling of Fe.  It
impairs absorption as well as increases the loss of gastrointestinal endogenous Fe.  The
hyperproliferation of crypt cells and an increased rate of transit of enterocytes along the
villi seem to cause the effects observed with absorption and gastrointestinal loss
(Powers, 1995).  The problem seen with the crypt cells and enterocytes along the villi
probably lead to the development of functionally immature villi which reduces the
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absorptive surface area for Fe.  The Fe loss was also linked to the high turnover rate of
the epithelial cells of the small intestine when there was a riboflavin deficiency (Powers,
1995).
Studies in geographical areas of the world that have a high rate of malaria have
shown that riboflavin-deficient human subjects are relatively resistant and have a lower
parasite burden than those subjects that are adequately nourished (Bender, 2002; Rivlin
and Pinto, 2001).  Although the biochemical basis of why this occurs is unknown, there
are two proposed mechanisms.  First the malarial parasites require a relatively high level
of riboflavin.  A decrease in riboflavin impairs the growth of parasites because they are
not getting the required amounts of the vitamin.  Secondly, because of an impaired
antioxidant activity in the erythrocytes, the erythrocyte membrane might be more fragile
or have reduced membrane fluidity.  This may expose the parasites to the host’s immune
system at a more vulnerable stage which results in the production of antibodies.  This is
similar to the sickle cell trait which also protects against malaria (Bender, 2002; Rivlin
and Pinto, 2001; Bhaskaram, 2002).
Although there is thought to be an effect of riboflavin deficiency on physical
performance, there are very few studies that actually support this.  It is believed that in
countries where there is no evidence of malnutrition that the riboflavin status is different
between athletes and nonathletes.  There is also no evidence that riboflavin supplements
increase performance in healthy, well nourished individuals (Powers, 2003).  A study on
women showed that, while aerobic exercise increased the riboflavin requirements,
additional riboflavin intake improved endurance.  However, pregnant women, who
participated in a walking program and took vitamin-mineral supplements containing
riboflavin, slightly improved their aerobic capacity (Perelson and Ellenbogen, 2002).
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Riboflavin deficiencies can be treated with oral doses of riboflavin up to 25 mg. 
A  single dose greater than this cannot be completely absorbed by the body even though
it is safe to administer.  The absorption of the administration dose is limited by the low
solubility of riboflavin (Rivlin, 2002) and the storage capacity (Rivlin and Pinto, 2001). 
Animal studies have shown an upper limit to tissue storage of flavins that cannot be
exceeded under normal circumstances.  The storage capacity of the tissues is presumably
limited by the availability of proteins that provide binding sites for the flavins (Rivlin
and Pinto, 2001).  Although consumption of mega-doses of riboflavin have not been
shown to be toxic, there is a theoretical risk for the administration of riboflavin.  It has
photosensitzing properties which may result in DNA degradation and an increase in the
formation of lipid peroxides (Misra et al., 2001; Rivlin, 2002).  When riboflavin forms
an adduct with tryptophan, the photodegradation is accelerated.  Administration of
riboflavin to the skin may increase the synthesis of melanin because of the stimulation of
free-radicals which increases the risk of skin cancer (Rivlin and Pinto, 2001).
There has been experimentation in people with riboflavin sustained release
floating capsules for the treatment of riboflavin deficiencies.  The theory behind these
capsules is that riboflavin is not always readily absorbed because of the fast passage rate
(El-Samaligy et al., 2003).  The capsules are prepared with a component such as sodium
bicarbonate which is liberated by the CO2 content of the stomach and rises to the top of
the content of the stomach.  By having the riboflavin pass through towards the end of the
digestion, the passage rate is slowed to provide more time for riboflavin to be in contact
with the small intestine (El-Samaligy et al., 2003).  This study showed an increase of
riboflavin concentration in the body using the capsules that caused the vitamin to float to
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the top compared to the capsules that did not cause the vitamin to float to the top (El-
Samaligy et al., 2003).
Riboflavin Detection
Fluorimetry
The AOAC methods for direct fluorimetric detection of riboflavin are based on
the conversion of FAD and FMN to riboflavin giving a measurement of the total
riboflavin in the sample.  Direct fluorimetry quantitates riboflavin using fluorescence
measurements that use an input filter of narrow T range with a wavelength maximum of
440 nm and a narrow T output range with a wavelength maximum of 565 nm.  To
prepare the sample for this procedure and reduce any background fluorescence, the
sample is acidified with glacial acetic acid and oxidized with potassium permanganate. 
After two minutes, the excess potassium permanganate is destroyed with hydrogen
peroxide (Eitenmiller and Landen, 2000).
Indirect fluorimetry can also be used to determine riboflavin concentration.  This
method utilizes the lumiflavin to quantitatively determine the amount of riboflavin.  The
lumiflavin is formed when the sample is irradiated under alkaline conditions.  It
fluoresces more strongly than free riboflavin, and it is chloroform soluble which
provides a means of removing interfering fluorescent compounds from the sample
matrix.  This procedure is more sensitive than direct fluorimetry of riboflavin due to the
increased fluorescence of lumiflavin.  Although this procedure is not commonly used in
the United States, it is able to eliminate sensitivity problems and poor chromatograms
that are associated with the direct analysis of riboflavin (Eitenmiller et al., 2000).  Both
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of the fluorometric methods have some documented weaknesses.  They have a tendency
to overestimate the total riboflavin content which is due to the interference from
fluorescing impurities from the sample matrix (Russell and Vanderslice, 1992).
HPLC
HPLC, high performance liquid chromatography, has many advantages.  It can be
developed for almost any pharmaceutical or biological matrix, it is sensitive, specific,
fast (Eitenmiller and Landen, 2000), and can assay multiple vitamins simultaneously
(Russell, 2000).  The drawbacks of this assay is that it requires expensive equipment and
trained personnel.  In addition, the determination of naturally occurring vitamins is
somewhat limited and it cannot be guaranteed that it is able to account for all the active
forms of a vitamin that would normally be quantified in a microbial assay (Ball, 1994). 
HPLC may also underestimate vitamin content (Ball, 1994).  Extraction from the food
matrix is usually the greatest challenge for vitamin analysis, especially when the
vitamins are often bound to other food constituents such as carbohydrates and proteins
(Russell, 2000).
For HPLC detection, ultraviolet absorbance is probably the most common
method followed by fluorescence and electrochemical detection.  The fluorescence and
electrochemical detection are generally used when physiochemical properties permit and
increased sensitivity and selectivity are desired.  Refractive index can also be used, but it
is not a common procedure because it lacks specificity and sensitivity (Russell and
Vanderslice, 2000).
An interlaboratory comparison of HPLC and microbiological methods for total
riboflavin revealed significant variability between the 13 labs that participated.  The
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most likely source of the of the variability seems to be the extraction and hydrolysis
methods used by the different laboratories (Russell, 2000; van den Berg et al., 1996).
Immunoassays
Immunoassays and protein-binding assays are also possible for the quantification
of vitamins.  These assays are as sensitive as the other methods and are less prone to
interference.  Large numbers of samples can be run using ELISAs and non-isotopic
protein-binding assays that utilize microtiter plates.  These assays do not have the
problem of handling and disposing of radioactive waste (Ball, 1994).  The immunoassays
and protein-binding assays chemically or enzymatically extract the vitamins from the
food matrix to ensure the riboflavin is in its free form before being run on the microtiter
plate.  The use of these assays depends on the successfulness, applicability, and
validation as well as the commercial availability of standardized kits (Ball, 1994).
Microbiological assays
Test organisms for vitamin assays must specifically require the selected
organism of interest to be genetically constant during prolonged response, have a rapid
growth cycle, have a growth response that is not easily influenced by neutralization salts
or other substances that may be present in a sample extract, and be nonpathogenic (Voigt
and Eitenmiller, 1985). 
A recent method developed for the determination of riboflavin in samples
involves agar-diffusion.  This is able to measure riboflavin concentrations in biological
samples using the bacterium Bacillus cereus.  The studies conducted found this assay to
be highly reproducible, sensitive, rapid, inexpensive, and can be applied to measure the
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amount of riboflavin in desired samples.  This assay is considered a good candidate for
the screening of bacteria growing on media that secrete riboflavin (Salvetti et al., 2003).
The classical way to determine riboflavin concentrations in samples is to use the
microbiological method using Lactobacillus rhamnosus ATCC 7469.  The assay is
almost universally used and applicable to most matrices.  The microbial assay has
equipment, bacterial cultures, and ready-made media commercially available, and the
assay procedure for riboflavin is standardized (Ball, 1994).  Microbial assays have the
advantage of space, labor, materials, and time over biological methods using animals
(Voigt and Eitenmiller, 1985).  Vitamin determination using microbiological methods is
based on the nutritional requirement of the specified organism for the vitamin of interest. 
A basal medium provides all of the growth requirements for the organism except the
vitamin being assayed.  A growth response curve can be generated using a defined
concentration range.  The growth response is directly proportional to the amount of
vitamin added to the medium.  To determine the amount of vitamin present in the
sample, the growth can be measured photometrically or metabolic products can be
monitored (Voigt and Eitenmiller, 1985).
Organisms other than L. rhamnosus that have riboflavin requirements are
Leuconostoc mesenteroides and a protozoan Tetrahymena pyriformis, but these
organisms have not been used much for riboflavin assays.  T. pyriformis requires 4-5
days to achieve a stable growth response.  This is a longer time than that of L. rhamnosus
which takes 16-18 hours.  T. pyriformis is also more sensitive to matrix interference and
to citrate ions that can be present in food extracts than L. rhamnosus (Eitenmiller and
Landen, 2000).  
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   Because FMN and FAD have very different growth-promoting effects and L.
rhamnosus’ response to free riboflavin is significantly greater than that of its coenzymes,
the FMN and FAD in the sample have to be converted to free riboflavin.  This is
achieved by acid hydrolysis.  The AOAC International extraction procedure (Chapter
45.2.06, Method 940.33) is the most common method used for riboflavin determination. 
It uses hydrolysis with 0.1 N HCl at 121C for 15 minutes to treat the sample.  The
filtrate pH is adjusted to 6.8 with sodium hydroxide prior to incorporation into the assay. 
This acid hydrolysis sufficiently converts FAD and FMN to free riboflavin for utilization
by L. rhamnosus (Eitenmiller and Landen, 2000).  The drawback of this procedure is the
cumbersome nature, long incubation times, tedium, and poor precision (Ball, 1994).  
Lactobacillus rhamnosus
To do a microbiological assay on a specific nutrient, a bacterium or yeast that is
an auxotroph is needed.  This means that the organism being used to detect the desired
nutrient requires the nutrient, but is not able to synthesize it.  For the riboflavin
microbiological assay, the bacterium of choice is Lactobacillus rhamnosus which was
formerly known as Lactobacillus casei subspecies rhamnosus ATCC 7469.  It requires
riboflavin for growth, but it is not able to synthesize it on its own which makes it a good
candidate to use for the quantitative determination of riboflavin in samples (Angyal,
1995).  
Lactobacillus rhamnosus is a gram positive, non-spore forming rod that grows
best between 15C and 45C.  This bacterium is also microaerophilic which indicates
that growth on solid media is usually enhanced by anaerobiosis and 5-10% CO2 (Sneath
et al., 1986).   The pH requirements for this organism are slightly acidic and optimal
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between 5.5 and 6.2 for growth, but growth ceases when a pH of 4.0-3.6 is reached.  The
growth rate is often reduced at a neutral or alkaline pH (Sneath et al., 1986).
This bacterium is often found in food products such as dairy, grain, meat, fish,
water, beer, wine, fruits, pickled vegetables, sauerkraut, and sour dough.  They can also
be found in sewage, silage, and mash as well as the natural flora in the mouth and
intestinal tract of many homothermic mammals including humans.  Pathogenicity of this
organism is extremely rare (Sneath et al., 1986).
Rationale and Significance
Riboflavin is an essential part of the diet because it cannot be synthesized by
many mammals (Bacher et al., 2000).  Because this compound is a required, it is
considered a vitamin and is also known as vitamin B2 (Carpenter, 2003).  Detection and
determination of riboflavin in food and animal feed samples is important to ensure that
the minimum amount of riboflavin required for normal growth is being obtained in the
diet.  The human population does not generally have a problem with meeting the
minimum riboflavin requirement if a balanced diet is consumed.  Certain parts of the
world in which the main food source is rice is found to have a more significant riboflavin
deficiency problem (Laskshmi, 1998).  There can also be a problem when food is
processed before consumption because this can have an effect on the riboflavin content. 
The factors that can affect riboflavin concentration in food products are heat, moisture,
oxygen, pH, and light.  These factors can be encountered through milling, fermentation,
germination, extrusion, and thermal processing (Reddy and Love, 1999).  Because so
many different factors and processes can affect riboflavin and because many of the foods
consumed are processed, quantification of vitamin concentration in foodstuffs can be
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important to prevent riboflavin deficiencies in certain populations.  Quantification of
riboflavin is also important for the cereal grain products that are often fortified with
riboflavin to ensure people are receiving the recommended daily allowance (McNulty et
al., 1996).  Deficiencies can include lesions of the lips, desquamation of the tongue, and
abnormalities of skin around the vulva, anus, and prepuce (Bender, 2002).
Microbiological assays are a common way of determining vitamin concentrations
in food samples.  These assays have the advantage of equipment, ready-made media
commercially available, space, labor, materials, and time (Voigt and Eitenmiller, 1985). 
The riboflavin assay has been standardized for use with test tubes by AOAC (Ball,
1994), but this is assay has the capability of being more user friendly by adaptation to
microtiter plates.  The microbiological folic acid assay also uses the same bacterium, L.
rhamnosus ATCC 7469, and this assay was successfully scaled down to microtiter plates
(Horne, 1997).  The microtiter plate assay was able to save time, labor, and supplies and
was able to assay more samples at one time (Horne, 1997).  The adaptation to microtiter
plates for the riboflavin assay would produce the same advantages as that of the folic
acid assay.
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CHAPTER III
MICROTITER PLATE ADAPTATION OF RIBOFLAVIN TUBE ASSAY
Synopsis
Riboflavin is an essential part of the diet by playing a significant role in the
metabolism of carbohydrates, fatty acids, and amino acids. Many cereal-grain products
are currently being fortified with riboflavin to reduce the possibility of deficiency in diets
that are not normally sufficient in riboflavin.  The objective of this research was to
reduce time of the assay by scaling it down to microtiter plates while still maintaining the
precision of the original tube assay.  This scaled-down assay was utilized for the
determination of riboflavin in samples of commercial maize, commercial ground
soybean meal, and commercial breakfast cereals. The organism that is used most
commonly to quantitate riboflavin is Lactobacillus rhamnosus ATCC 7469.  The AOAC
approved riboflavin assay was used as a guideline for transferring the riboflavin assay
from a tube assay to a microtiter plate assay.  Riboflavin assay L. rhamnosus was grown
overnight at 37C for 8 hours and absorbances were read on a microtiter plate reader. 
The standard growth curve for the riboflavin assay was linear from 0 ng/mL up to 10
ng/mL with an average R2 value of 0.99.  The data showed no significant difference
between the tube assay and microtiter plate assay (P<0.05) for the commercial maize
sample.  Other samples were used to confirm reproducibility.  The microtiter assay
reduced the amount of time required for sufficient bacterial growth response to generate
linear standard curves from 22 hours to 14 hours. 
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Introduction
Riboflavin is an important requirement for most organisms.  Some organisms are
able to synthesize riboflavin while other organisms that are higher up in the food chain
cannot and must acquire riboflavin from their diet (McCormick, 1989).  Riboflavin can
be consumed in three forms which include free riboflavin, flavin mononucleotide
(FMN), and flavin adenine dinucleotide (FAD).  The last two represent the
phosphorylated forms (Powers, 1999).  Although all three forms are found
intracellularly, absorption occurs as riboflavin which is followed by intracellular
phosphorylation in the enterocytes.  FAD is the most common form or riboflavin present
in tissues and in circulation (Powers, 1999).  The coenzyme forms of riboflavin, FMN
and FAD, can serve as prosthetic groups of many holoenzymes.  These holoenzymes can
catalyze essential one and two electron oxidation-reduction reactions (McCormick,
1989).
Microbiological quantification of vitamins requires a microorganism that has a
need for a certain vitamin without being able to synthesize the vitamin being studied. 
This process allows for the use of a medium that contains all of the growth requirements
for the microorganism being used except the vitamin being assayed (Angyal, 1995).  The
vitamin of interest can be added to the media in certain concentrations to obtain a growth
curve for a specified amount of time.  A sample with an unknown concentration of the
vitamin of interest can also be determined by comparing the microorganism growth of
the sample with that of the standard curve (Voigt and Eitenmiller, 1985).  The riboflavin
assay has already been tested and proven to work in tubes using L. rhamnosus as the
microorganism (Angyal, 1995).  
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In the food processing industry, large numbers of samples need to be processed
quickly.  A rapid assay was developed for folic acid by adapting the tube assay to
microtiter plates (Horne, 1997).  The goal for developing the riboflavin assay was to
decrease the total amount of time required for the assay and make it easier to run more
samples at one time while retaining the accuracy and precision of the tube assay. 
Microtiter plates provide many benefits when compared to tube assays.  The
development of a microtiter plate assay can save commercial industry time, space,
material, and labor (Newman and Tsai, 1985).  Time can also be saved because many
more trials can be prepared and conducted simultaneously since microtiter plates do not
require as much space or media as tubes (Voigt and Eitenmiller, 1985).  
Because L. rhamnosus requires riboflavin to grow, has a rapid growth cycle, is
not easily influenced by substances that are present in sample, and is nonpathogenic, it is
a common organism to use for the quantification of riboflavin in samples (Voigt and
Eitenmiller, 1985).  L. rhamnosus is a nonsporing, gram positive rod bacterium.  It is
facultatively anaerobic, and when grown under anaerobic conditions, the fermentation
products produced are mainly lactate, but it may also give acetate, ethanol, and CO2
(Sneath et al.,1986).  L. rhamnosus is an obvious choice for studying riboflavin content
because it is simple to work with and is not a human pathogen (Sneath et al., 1986). 
This paper describes a microtiter assay for measuring riboflavin concentrations in
samples using a riboflavin auxotroph, L. rhamnosus, which is used in the standardized
tube riboflavin assay.
42
Materials and Methods
Bacterial strain
L. rhamnosus American Type Culture Collection (ATCC, Manassas, VA, USA) 
#7469 was the organism used in the riboflavin assays.  Stock cultures of L. rhamnosus
were transferred monthly into stab cultures consisting of 10 mL of Micro Assay Culture
Agar (Becton, Dickinson, and Company, Franklin Lakes, NJ, USA).  They were
incubated at 37C for 24-48 hours and transferred to a refrigerator held at 4C  for
storage.  A working culture was kept on a streak plate and was transferred weekly.  The
streak plate was stored at 4C.
To prepare the inoculum for the riboflavin assay, a subculture of the L.
rhamnosus stock culture was made by inoculating 10 mL of Micro Inoculum Broth.  The
broth was incubated for 16-24 hours at 37C.  The culture was centrifuged using aseptic
technique, and the liquid was decanted.  The cells were washed three times with 10 mL
of 0.85% sterile saline solution, and they were resuspended  in 10 mL of 0.85% sterile
saline solution.  Using a spectrophotometer at 600 nm, the absorbance of the cell
suspension was adjusted to 35-40% transmittance for tubes and 10-15% transmittance
for microtiter plates using sterile saline solution to dilute the cell suspension.  This cell
suspension, 20 L for tubes and 4 L for microtiter plates, was used to inoculate broth
for the assay.  Both the tubes and the micortiter plates were kept at 37C.  
Media preparations
The media was prepared by suspending 4.8 grams of Bacto® Riboflavin Assay
Medium (Becton, Dickinson, and Company, Franklin Lakes, NJ, USA) in 100 mL of
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deionized water.  The media was boiled 2-3 minutes to dissolve completely.  It was then
dispensed in 5 mL amounts into tubes.  The standard or test sample was added, and the
volume was adjusted to 10 mL using deionized water.  The tubes were autoclaved for 10
minutes at 121C.
Standard curve preparation
 The riboflavin stock solution was prepared by weighing 50 mg of riboflavin
standard (Sigma) and dissolving it in 500 mL of deionized water in a volumetric flask. 
Then, it was further diluted by adding 0.5 mL to 500 mL of deionized water in a
volumetric flask.  The diluted stock solution was distributed in the tubes using 0.0, 0.25,
0.5, 0.75, 1.0, 1.5, 2.0, and 3.0 mL per tube. These volumes were adjusted to 10 mL with
5 mL of media and deionized water which gave riboflavin concentrations of 0.0, 2.5, 5.0,
7.5, 10, 15, 20, and 30 ng/mL.  The tubes were prepared in duplicate.  The stock solution
for the standard curve was prepared fresh daily to prevent deterioration of riboflavin in
the solution.
Culture growth conditions
Cell growth was measured turbidimetrically at 600 nm (A600) on a Milton Roy
Spectronic 20D spectrophotometer for the tubes and a Tecan Spectra Fluor Plus
(Research Triangle Park, NC) for the microtiter plates.  The tube assays were allowed to
grow for 18-24 hours as recommended by the commercial supplier  (Becton, Dickinson,
and Company, Franklin Lakes, NJ, USA) while the microtiter plates were allowed to
incubate for 14-22 hours.  The cells exhibited a lag phase growth period which is defined
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by the time period between the initiation of growth on the growth curve and exponential
phase of the growth curve.
Sample preparation
Samples were weighed to 0.500g +/- 0.01g and transferred to an anaerobic
culture tube.  To each sample, 12.5 mL of 0.1 M sulfuric acid was added, and a crimped
top was added to the tube.  The samples were autoclaved for 15 minutes along with the
prepared riboflavin standard tubes.  After removing the tubes from the autoclave and
cooling, they were vortexed and the pH was adjusted to 6.8 using 0.37 N sodium
hydroxide.  The volume was then adjusted to a final volume of 25 mL with deionized
water.  The samples were poured into 50 mL centrifuge tubes and centrifuged for 10
minutes at 5000 rpm.  The samples were filtered with a 0.2 m syringe filter (Whatman,
Clifton, NJ, USA) into a sterile 50 mL centrifuge tube.  They were disbursed into tubes
containing 5 mL of Bacto® Riboflavin Assay Medium (Becton, Dickinson, and
Company, Franklin Lakes, NJ, USA) and deionized water, and were autoclaved along
with the prepared riboflavin standard tubes.  The final tube volume was 10 mL after the
sample was added.  The samples were kept either in tubes for the tube assay or
transferred to microtiter plates.  They were inoculated with the same amount of bacterial
solution as the standard curve and subjected to the same growth conditions as the
respective riboflavin standard.
Nalidixic acid preparation
Nalidixic acid was added to deionized water to generate a stock solution which
was filtered through a 0.2 m syringe filter.  Nalidixic acid was added to the sample
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tubes after they were autoclaved and cooled.  The final concentration of nalidixic acid in
the sample tubes was 20 g/mL per tube.
Statistical analysis
The data generated using the microbiological riboflavin assays were analyzed
using the Duncan’s test and regression analysis.  All statistical analysis was considered
significant at P<0.05.  The statistical data were generated using Statistical Analysis
Software 8.0 (SAS) (SAS Institute, Cary, NC, USA).
Results and Discussion
Nalidixic acid
Nalidixic acid was used in this study to decrease the possibility of contamination
of media.  This antibiotic was selected for use after screening L. rhamnosus with a range
of antibiotics that included tetracycline, erythromycin, neomycin, nalidixic acid, and
kanamycin.  The only antibiotic that L. rhamnosus showed a natural resistance to was
nalidixic acid.  To ensure that nalidixic acid did not retard the growth of L. rhamnosus,
standard curves with nalidixic acid were compared with those that did not have the
antibiotic.  The results of these studies are depicted in figure 3.1.  The nalidixic acid was
found to have no effect on the growth of L. rhamnosus for the riboflavin assay. 
Microtiter plate modifications
By 1940, remarkable achievements were being made with bacterial assays.  This
work permitted researchers to make progress in one year that would have otherwise 
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Figure 3.1: Comparison of microtiter plate riboflavin standard curve with the standard
curve plus nalidixic acid.
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taken ten or more years (Kavanagh, 1963).  Further modification of the bacterial assays
to microtiter plates can save even more time.  Microtiter plates have been successfully
developed for the detection of bacterial growth to quantify organisms via most probable
number (Hernandez, 1991).  Microtiter plates have also been used to modify the folic
acid tube assay using L. rhamnosus.  This assay improved the analysis by allowing more
samples per day with a sensitivity comparable to that of the tube assay (Newman and
Tsai, 1985; Horne, 1997).  The microtiter scaling of the folic acid assay proved to reduce
culture volumes by 10-fold compared with other suspension culture microbiological
assays.  By decreasing culture volumes, the cost of reagents and minimum amount of
folate measurable was proportionately lower (Newman and Tsai, 1985).  The
modifications made to the folate assay using microtiter plates retained the sensitivity and
selectivity of procedures previously done to detect folate (Newman and Tsai, 1985).  The
growth rate of the riboflavin assay was determined for tubes as well as microtiter plates. 
Microbial growth in microtiter plates reached its maximum approximately 4 hours before
the tube assay reached its maximum growth (figure 3.2).  This allows for more rapid
results with the microtiter plate assay versus the tube assay.
To test the suitability of the microtiter plate approach for assaying riboflavin
concentrations in samples, riboflavin concentration was determined in a commercial
maize sample and used to compare the microtiter plate assay with the standardized tube
assay.  Each microtiter plate assay was run simultaneously with a tube assay for
comparison.  A standard curve was prepared each time a trial was run.  It was important
to construct a standard curve each time the assay was run because of fluctuations in
autoclaving conditions, incubation temperature, and other environmental conditions that
cannot be controlled.  Slight differences in these variables could influence the standard
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curve readings in each trial.  The riboflavin concentration in the commercial maize
sample was determined by using the absorbance at 600 nm for each sample and putting it
into the equation that was generated from the standard curve for each trial.  This number
was then converted into milligrams of riboflavin per kilogram of sample for ease of
comparison between samples.  
Sample results
The reproducibility of results is important for quantification of riboflavin in the
assay.  The six riboflavin tube assay trials verified that there was no significant
difference between any one trial (figure 3.3).  Six riboflavin microtiter plate assay trials
also verified that there was no significant difference between any one trial (figure 3.4).  It
is also important to determine if the developed microtiter plate assay is as accurate and
compared to the tube assay(figure 3.5).  This figure shows no significant differences
between the microtiter plate assay and the tube assay for the determination of riboflavin
concentration.
Other samples were also used to determine the reproducibility of the riboflavin
microtiter plate assay.  These samples included ground soybean meal, commercial
oatmeal, commercial cornflakes breakfast cereal, commercial rice squares breakfast
cereal, and commercial wheat squares breakfast cereal.  They were chosen because many
cereals are fortified with riboflavin to enhance a balanced diet, and they were available
commercially.  These samples were treated with acid and autoclaved to get an accurate
determination of riboflavin content.  Acid hydrolysis of the samples is important for the
conversion of biological forms of riboflavin known as flavin mononucleotide (FMN) and
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Tube vs. Microtiter Plate Growth Comparison
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Figure 3.2: Comparison of growth rates for riboflavin tube assay and riboflavin
microtiter plate assay.  There were three tubes per trial (n =3) and six trials for each
point.  For the microtiter plate there were eight wells per trial (n = 8) and six trials for
each point.
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Maize Tube Trial Comparison
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Figure 3.3: Shows the consistency between trials for the riboflavin tube assay using
commercial source of maize as a sample using the standard deviation.  There was no
significant difference between trials (P<0.05).  Each trial had three replicates.
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Maize Microtiter Plate Trial Comparison
0.0000
0.2000
0.4000
0.6000
0.8000
1.0000
1.2000
1.4000
1.6000
1.8000
2.0000
Trial 1 Trial 2 Trial 3 Trial 4 Trial 5 Trial 6R
ib
o
fla
v
in
 
Co
n
ce
n
tr
at
io
n
 
(m
g/
kg
)
Figure 3.4: Shows the consistency between trials for riboflavin microtiter assay using
commercial source of maize for sample using standard deviation.  There was no
significant difference between trials (P<0.05).  Each trial had three replicates.
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Microtiter Plate vs. Tube for Maize Data
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Figure 3.5: Comparison of riboflavin tube assay with the microtiter plate assay using
commercial source of maize as sample using standard deviation.  There was no
significant difference between trials (P<0.05).  Six trials were averaged for the values.
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precise as the standardized tube assay.  To determine if there was a significant difference
between the microtiter plate assay and the tube assay, the microtiter plate assay was
flavin adenine dinucleotide (FAD) to riboflavin so the L. rhamnosus can give an accurate
determination of riboflavin (Eitenmiller and Landen, 2000).  The final pH of the sample
is extremely important because once a certain pH is reached, the riboflavin becomes
biologically inactive so an accurate determination of riboflavin the sample is not possible
(Ottaway, 2002; Prodanov et al., 2004).  The best pH for sample determination that does
not reduce the biologically available riboflavin but allows for the optimum growth of L.
rhamnosus is 6.8 (Ottaway, 2002; Sneath et al., 1986).  Once the sample has reached a
pH of 6.8, any slight rise in pH will cause the biologically active riboflavin to diminish
and become unusable to the bacteria.  If bacteria can not utilize the riboflavin, they will
not grow, and  the sample readings would not be accurate.
The ground soybean meal sample did not show any difference (P>0.05) in the of
riboflavin quantification between trials.  The samples of oatmeal and cornflakes showed
some significant differences between samples.  This could be due to the fact that the final
pH was slightly above the optimum.  A comparison between the three trials for ground
soybean meal, oatmeal, and cornflakes are depicted in figures 3.6, 3.7, and 3.8
respectively.  The samples of rice squares and wheat squares did not show any
significant differences of riboflavin between trials (figures 3.9 and 3.10 respectively).
Conclusions
The conversion of the riboflavin assay to a microtiter plate assay was successful. 
The results showed no statistical difference between the riboflavin quantification when
the assay was performed in the tubes versus the microtiter plate.  The reproducibility of
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the microtiter assay was also successful for maize, cornflakes, rice squares, and wheat
squares.  There was some differences in the oatmeal and soybean meal trials, but this
could be due to slight variations in final pH which can affect riboflavin concentrations.
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Soybean Trial Comparison
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Figure 3.6: Comparison of microtiter plate trials determining riboflavin content in
soybeans using standard deviation.  There was no significant difference between trials
(P<0.05).  Each trial had eight replicates.
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Oatmeal Trial Comparison
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Figure 3.7: Comparison of microtiter plate trials determining riboflavin content in
oatmeal using standard deviation.  The difference in letters shows statistical difference. 
Trial 1 is not statistically different from both Trial 2 and 3, but Trials 2 and 3 are
statistically different from each other.  Each trial had eight replicates
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Cornflake Trial Comparison
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Figure 3.8: Comparison of microtiter plate trials determining riboflavin content in
cornflakes using standard deviation.  The difference in letters shows statistical
difference.  Trial 3 is not statistically different from both Trial 1 and 2, but Trials 1 and 2
are statistically different from each other.  Each trial had eight replicates.
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Rice Squares Trial Comparison
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Figure 3.9: Comparison of microtiter plate trials determining riboflavin content in rice
squares cereal using standard deviation.  There was no significant difference between
trials (P<0.05).  Each trial had eight replicates
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Wheat Squares Comparison
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Figure 3.10: Comparison of microtiter plate trails determining riboflavin content in
wheat squares cereal using standard deviation.  There was no significant difference
between trials (P<0.05).  Each trial had eight replicates.
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CHAPTER IV
ANAEROBIC RIBOFLAVIN ASSAY ADAPTATION
Synopsis
An anaerobic riboflavin microtiter assay was developed to reduce the amount of
time for Lactobacillus rhamnosus to grow prior to an optical density reading.  Anaerobic
conditions were incorporated into the assay through the use of an anaerobic hood, and
the incorporation the reducing agents ascorbic acid, dithiothreitiol, and thioglycolate. 
The reducing agents were used in various concentrations: 0.05%, 0.075%, and 0.1%
(w/v) of ascorbic acid, 0.01%, 0.025%, and 0.05% (w/v) for dithiothritol, and 0.01%,
0.1%, and 0.2% (w/v) for thioglycolate.  It was found that the use of an anaerobic hood
significantly increased the growth of L. rhamnosus during the assay, but it did not reduce
the assay time.  None of the concentrations of any of the reducing agents had a
significant effect on the assay growth.  
Introduction
Through food processing, a significant amount of riboflavin can be lost due to
heat, moisture, oxygen, pH, and light (Ottaway, 2002).  Many cereals are now being
fortified with different vitamins including riboflavin which provides a more balanced
diet for those people who do not receive enough vitamins through a regular diet
(McNulty et al., 1996).  To ensure the labels for the fortified foods as well as non-
fortified foods have the correct riboflavin content, a rapid riboflavin assay is required. 
The first step toward accelerating the assay was to convert it from a tube assay to a
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microtiter plate assay. The second step is to decrease the amount of time it takes for L.
rhamnosus to reach the growth point where optical density readings can be taken.  
The riboflavin microtiter assay is prepared using a commercial riboflavin assay
medium (Becton, Dickinson, and Company, Franklin Lakes, NJ, USA).  This assay used
AOAC assay as a guideline for transferring the riboflavin assay from a tube assay to a
microtiter plate assay.  The transfer to microtiter plates reduces the time between
inoculation of the plate and measurement of absorbance.  This bacterium has a
significant lag phase during growth when the standardized riboflavin assay is performed. 
The lag phase requires time for microbial growth and may be due to the aerobic
conditions present during initiation of the assay.  To reduce the assay, studies using
anaerobic conditions were conducted.
  L. rhamnosus is a facultative anaerobe which indicates that it is capable of
growth in the presence of oxygen or with limited amount of oxygen (Sneath et al., 1986). 
As a lactic acid bacteria, they are gram-positive, fastidious in their nutritional
requirements, have enhanced growth under microaerophilic conditions and produce
considerable amounts of lactic acid(Reuter, 1985; Brown, 1968; Tharmaraj and Shah,
2003).  For optimum growth, a reduced oxygen content and approximately 10% of CO2
is recommended (Reuter, 1985). 
To reduce assay time even further by reducing the lag phase and accelerating the
growth of L. rhamnosus, the overall purpose of this study was to determine the effect of
anaerobic conditions and reducing agents, at various concentrations in the media, on the
riboflavin microtiter plate assay.  The anaerobic conditions were achieved by using an
anaerobic hood, and the reducing agents studied were ascorbic acid, dithiothreitol, and
62
thioglycolate.  Because L. rhamnosus is not a strict anaerobe, the concentration of the
reducing agents did not need to create a complete anaerobic environment. 
Materials and Methods
Bacterial strain
L. rhamnosus American Type Culture Collection (ATCC)  #7469 is the organism
used in the riboflavin assays.  Stock cultures of L. rhamnosus were transferred monthly
into stab cultures consisting of 10 mL of Micro Assay Culture Agar  (Becton, Dickinson,
and Company, Franklin Lakes, NJ, USA).  They were incubated at 37C for 24-48 hours
and transferred to the refrigerator at 4C  for storage.  A working culture was kept on a
streak plate and was transferred weekly.  The streak plate was stored at 4C.
To prepare the inoculum for the riboflavin assay, a subculture of the L.
rhamnosus stock culture was made by inoculating 10 mL of Micro Inoculum Broth 
(Becton, Dickinson, and Company, Franklin Lakes, NJ, USA).  The broth was incubated
for 16-24 hours at 37C.  The culture was centrifuged using aseptic technique, and the
liquid was decanted.  The cells were washed three times with 10 mL of 0.85% sterile
saline solution and were resuspended  in 10 mL of 0.85% sterile saline solution.  Using a
spectrophotometer at 600 nm, the absorbance of the cell suspension was adjusted to 35-
40% transmittance for tubes and 10-15% transmittance for microtiter plates using sterile
saline solution to dilute the cell suspension.  This cell suspension, 20 L for tubes and 4
L for microtiter plates, was used to inoculate broth for the assay.  Both the tubes and
the micortiter plates were kept at 37C.  
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Media preparations
The media was prepared by suspending 4.8 grams of Bacto® Riboflavin Assay
Medium (Becton, Dickinson, and Company, Franklin Lakes, NJ, USA) in 100 mL of
deionized water.  The medium was boiled 2-3 minutes to dissolve completely.  It was
then dispensed in 5 mL amounts into tubes.  The standard or test sample was added, and
the volume was adjusted to 10 mL using deionized water.  The tubes were autoclaved for
10 minutes at 121C.  It was important to keep the riboflavin assay medium at 2-8C
and to keep the container tightly closed because the medium is very hygroscopic. 
Standard curve preparation
 The riboflavin stock solution was prepared by weighing 50 mg of riboflavin
standard (Sigma) and dissolving in 500 mL of deionized water in a volumetric flask.  It
was further diluted by adding 0.5 mL to 500 mL of deionized water in a volumetric flask. 
The diluted stock solution was distributed in the tubes using 0.0, 0.25, 0.5, 0.75, 1.0, 1.5,
2.0, and 3.0 mL per tube. These volumes were adjusted to 10 mL with 5 mL of media
and deionized water which gave riboflavin concentrations of 0.0, 2.5, 5.0, 7.5, 10, 15, 20,
and 30 ng/mL.  The tubes were prepared in duplicate.  The stock solution for the
standard curve was prepared fresh daily to prevent deterioration of riboflavin in the
solution.
Culture growth conditions
Cell growth was measured turbidimetrically at 600 nm (A600) on a Milton Roy
Spectronic 20D spectrophotometer for the tubes and a Tecan Spectra Flour Plus
(Research Triangle Park, NC) for the microtiter plates.  The tube assays were allowed to
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grow for 18-24 hours as recommended by AOAC while the microtiter plates were
allowed to incubate for 14-22 hours.  The cells exhibited a lag phase growth period
which is defined by the time period between the initiation of growth on the growth curve
and exponential phase of the growth curve.
Anaerobic conditions
The anaerobic conditions were achieved through an anaerobic hood as well as the
use of reducing agents.  A standard curve of each trial was prepared for comparison. 
One of the microtiter plates was prepared as previously described and placed in the
anaerobic hood.  It was subjected to the same temperature and time frame for growth as
the aerobic standard curve.  The microtiter plate from the anaerobic hood was read after
six hours for the first absorbance reading.  The wells were mixed using a micro pipette to
gently pipet the contents up and down of wells to reduce the amount of air introduced
into the sample through mixing.  After the absorbance reading was taken, the plate was
returned to the anaerobic chamber.  The first absorbance reading was followed by
subsequent readings at two hour intervals which were subject to the same treatment.  
The reducing agents incorporated into the media were ascorbic acid,
dithiothreitol, and thioglycolate at varying concentrations.  The ascorbic acid
concentrations were 0.05%, 0.075%, and 0.10%.  The dithiothreitol concentrations were
0.01%, 0.025%, and 0.05%.  The thioglycolate concentrations were 0.01%, 0.1%, and
0.2%.  These percentages were determined using methods described by Levett (1991).  A
standard curve was prepared as previously described, and the various reducing agents
were added to the assay tubes at the desired concentration before they were transferred to
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the microtiter plate.  The sample microtiter plates were subject to the same temperature
and growth conditions as the prepared standard curve.  
Statistical analysis
The data generated using the microbiological riboflavin assays were analyzed
using regression analysis.  All statistical analysis were considered significant at P<0.05. 
The statistical data was generated using Statistical Analysis Software 8.0 (SAS) (SAS
Institute, Cary, NC, USA).
Results and Discussion
Growth responses of L. rhamnosus to anaerobic conditions at various times are
depicted in figures 4.1 through 4.4.  The aerobic versus anaerobic trials were performed
three times, and the results were averaged for the respective standard riboflavin
concentrations.  To determine if there was a significant difference between the two
growing conditions, each standard curve was graphed at the varying times of optical
density readings and regression analysis was performed.  The times that optical density
readings were taken were 8, 10, 12, and 14 hours after inoculation.  The readings were
not performed more this because the microtiter plates had to be exposed to oxygen every
time the plate was taken from the anaerobic hood. Also, to reduce the amount of air
incorporated into the inoculated media, the cell suspension was mixed using pipets.
There was a significant difference in the growth response for absorbance readings
taken at hours 8 through 14 compared to the standard that was not subjected to anaerobic
conditions.  The results from the linear regression analysis confirmed significant
differences in the OD values between the aerobic and anaerobic conditions.  Although 
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Riboflavin Microtiter Plate Assay at 8 Hours
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Figure 4.1: Comparison of aerobic growth and anaerobic growth of the riboflavin assay
standard curve after 8 hours.  Each concentration is an average of eight replicates.
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Riboflavin Microtiter Assay at 10 Hours
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Figure 4.2: Comparison of aerobic growth and anaerobic growth of the riboflavin assay
standard curve after 10 hours.  Each concentration is an average of eight replicates.
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Riboflavin Microtiter Assay at 12 Hours
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Figure 4.3: Comparison of aerobic growth and anaerobic growth of the riboflavin assay
standard curve after 12 hours.  Each concentration is an average of eight replicates.
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Riboflavin Microtiter Plate Assay at 14 Hours
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Figure 4.4: Comparison of aerobic growth and anaerobic growth of the riboflavin assay
standard curve after 14 hours.  Each concentration is an average of eight replicates.
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the cells for each riboflavin concentration were greater in the anaerobic conditions, the
rate of growth was the same.  The growth curve for the anaerobic standard compared to
the aerobic standard is presented in figure 4.5 which showed that the slopes of the
anaerobic and aerobic regression lines are the same.  The purpose of this study was to
determine if results could be obtained more rapidly by decreasing the lag phase of the
bacteria.  This was not the case since the growth rates of bacteria subjected to anaerobic
and aerobic conditions are the same.  The study does illustrate that the total growth
measured by the OD value does increase with anaerobic conditions, but the growth rate
does not change.  The assay reached maximum growth after 14 hours post inoculation
whether subjected both anaerobic or aerobic conditions.
Ascorbic acid, also known as vitamin C, is a natural antioxidant and protects
against free radical damage (Hathcock et al., 2005).  This compound was chosen for use
in this study because it is non-toxic to humans and is a proven reducing agent (Smith and
Pierson, 1979).  Dithiothreitol and thioglycolate, although they have minor warnings
about skin and eye irritation, are relatively safe to work with when gloves are used
(Nebra et al., 2002).  They are also proven reducing agents, and therefore, chosen for
incorporation into the riboflavin assay media (Nebra et al., 2002; Kirakosyan et al.,
2004).
Studies by Smith and Pierson (1979) proved that ascorbic acid and thioglycolate
were able to reduce the amount of oxygen in media while Kirakosyan et al.(2004)
demonstrated the ability of dithiothreitol to also reduce the amount of oxygen present in
the prepared media. Three trials were conducted for each concentration of each reducing
agent.  The three trials for each reducing agent were averaged and the average natural log
of the absorbance graphed over time to generate a growth curve for each concentration. 
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The standard curves that were generated from varying concentrations of reducing agents
did not show a significant difference in growth response (figures 4.6 through 4.8).  These
graphs, as well as the linear regression analysis, show that the growth of L. rhamnosus
when inoculated into media containing the various reducing agents was not affected in
neither a positive nor negative manner when compared to the unmodified riboflavin
standard curve.
Conclusions
Although the anaerobic adaptations increased the amount of growth, the growth
rate did not increase as expected.  The anaerobic adaptation was not effective at
accelerating growth whether the L. rhamnosus was grown under aerobic or anaerobic
conditions in microtiter plates.  The reducing agents did not prove to affect the growth of
L. rhamnosus in any manner.  The addition of reducing agents in the media had no effect
on growth rate.
72
Growth Curve of Anaerobic vs. Aerobic
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Figure 4.5: Comparison of aerobic growth and anaerobic growth of the riboflavin assay
standard curve using the natural log of the average of optical density readings at a
riboflavin concentration of 30 ng/mL.   The graph shows no significant difference
between the slopes of the two trials (P<0.05).  Each concentration is an average of eight
replicates.  
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Growth Curve of Riboflavin Assay Using 
Ascorbic Acid 
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Figure 4.6: Comparison of growth curves using concentrations of ascorbic acid ranging
from 0.05% to 0.1% against the riboflavin standard curve.  Each concentration is an
average of eight replicates. 
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Growth Curve of Riboflavin Assay Using 
Dithiothreitol
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Figure 4.7: Comparison of growth curves using concentrations of dithiothreitol ranging
from 0.01% to 0.05% against the riboflavin standard curve.  Each concentration is an
average of eight replicates.
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Growth Curve of Riboflavin Assay Using 
Thioglycolate
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Figure 4.8: Comparison of growth curves using concentrations of thioglycolate ranging
from 0.01% to 0.2% against the riboflavin standard curve.  Each concentration is an
average of eight replicates.
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CHAPTER V
CONCLUSIONS
The development of a more rapid microtiter riboflavin assay using L. rhamnosus
was presented.  This assay  is important for the food industry to allow for more rapid
determination of riboflavin in food sources and enable more samples to be analyzed at
one time.  Riboflavin is an essential part of the diet and is incorporated into many
metabolic functions of the body.  Deficiencies can be a problem in regions of the world
where the main staple is rice.  To prevent and cure riboflavin deficiencies, many cereal
grains are being fortified with riboflavin.  With the fortification of riboflavin in many
cereal grains and the detrimental effects of certain processing procedures on riboflavin
concentration, verifying riboflavin content in these foods is especially important.  
The objective of this study was to modify the accepted AOAC riboflavin tube
assay by scaling down to microtiter plates and evaluating the anaerobic conditions to
reduce the lag phase of L. rhamnosus.  The goal of these changes was to produce a more
rapid assay and save on test materials.
The microtiter plate adaptation required four hours less time as compared to the
tube assay.  The final incubation time from the time of inoculation until the final reading
was reduced from 18 hours down to 14 hours.  The precision of the assay was
determined using a commercial maize sample.  A comparison between the AOAC
approved tube assay and the microtiter plate assay showed no significant differences
between the methods.  Other samples were also assayed for riboflavin concentration to
determine the reproducibility of the microtiter plate riboflavin assay.  Commercial
soybean meal, rice squares, and wheat squares all showed consistency between trails
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with no significant differences in riboflavin concentration.  Cornflakes and oatmeal
showed some differences between trials.  This could be caused by the pH being slightly
higher than the optimum 6.8.  Riboflavin begins to become biologically inactive above a
pH of 6.8.  The higher the pH rises, the more biologically inactive it becomes. 
Samples incubated under anaerobic conditions showed an increase in cell
number, but the growth rate was not significantly affected.  Because growth rate was not
affected by the anaerobic conditions, the final assay time were equivalent.  Reducing
agents, ascorbic acid, dithiothreitol, and thioglycolate, added to the media did not affect
the growth of L. rhamnosus in any fashion.  Growth remained constant between the
control and the treated samples containing the various concentrations of reducing agents. 
Neither the anaerobic conditions nor the reducing agents reduced assay time for the
microtiter plate assay.
Use of the microtiter plate assay for the determination of riboflavin in food
samples, reduces the assay time by about four hours.  This improvement saves not only
time and materials, but enables a larger number of assays to be performed.
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